Most Read News

Tech Mahindra: The IT company on Saturday announced that it has approved the proposal to acquire 100% equity shares in Thirdware Solutions. Thirdware, headquartered in Mumbai, is a global player in Enterprise Applications focused in the areas of ERP, BIA, Cloud and business technologies. Gail (India): Gail (India) said that its board has approved the payment of second interim dividend of Rs 5 per equity […]

In case, the Board decides to consider and declare the 2nd interim dividend, the record date for payment of Dividend would be March 29, 2022.

Zydus Lifesciences received the final approval from the US-based drug regulator, the United States Food & Drug Administration (USFDA) to market Colestipol Hydrochloride tablets (in the strength of 1mg).

NHPC had already paid Rs249.44 crore to Government of India during the current fiscal 2021-22 on account of final dividend for the financial year 2020-21.

The Indian rupee is expected to stay somewhat range bound in opening trades on Monday, 14 March 2022 as investors continue to monitor the Russia-Ukraine situation although easing crude oil prices could lend some support to the local unit. Meanwhile, resurgence of Covid wave in China is likely to dampen sentiments. Further, sustained foreign fund outflows from Indian market and dollar strength could weigh down […]

The report highlights Wipro as a good fit for large enterprises, bringing consultancy-led workplace transformation across geographies while saving costs.

Lupin said that it has received approval from the United States Food and Drug Administration (FDA) for Vigabatrin for oral solution USP.

Back in 2013, India was identified among the “Fragile Fiveâ€; economies most vulnerable to a post GFC taper. At that time the rupee and Sensex had crashed. This time, the Indian economy looks a lot stronger.

Zydus Lifesciences has received final approval from the USFDA to market Colestipol Hydrochloride Tablets in the strength of 1mg (US RLD: Colestid). Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Colestipol Hydrochloride is a highly complex macro molecule drug substance […]

Through this MoU, BSE and Onsurity will plan and undertake seminars, public relations events, press releases, testimonials, demonstrations.